Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avraham Ashkenazi

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Molecular Therapy. Nucleic Acids|November 18, 2024
A drug candidate for a rare polyalanine disease targeting the protein quality controlSharon Pochtar, Avraham Ashkenazi
Molecular Cell|January 5, 2019
The Cell-Death-Associated Polymer PAR Feeds Forward α-Synuclein Toxicity in Parkinson's DiseaseMaya Donyo, Avraham Ashkenazi
European Biophysics Journal : EBJ|January 25, 2011
Insights into the mechanism of HIV-1 envelope induced membrane fusion as revealed by its inhibitory peptidesAvraham Ashkenazi, Yechiel Shai
Nature Reviews. Molecular Cell Biology|March 24, 2020
Lipids as the key to understanding α-synuclein behaviour in Parkinson diseaseRoni Stok, Avraham Ashkenazi
Nature Reviews. Molecular Cell Biology|February 20, 2026
The emerging importance of UBA6 in ubiquitylation and proteostasisGali Prag, Avraham Ashkenazi
Trends in Cell Biology|September 2, 2019
The Nucleolus as a Proteostasis RegulatorFatima Amer-Sarsour, Avraham Ashkenazi
Luminescence : the Journal of Biological and Chemical Luminescence|March 18, 2009
Luminol-dependent chemiluminescence of human phagocyte cell lines: comparison between DMSO differentiated PLB 985 and HL 60 cellsAvraham Ashkenazi, Robert S Marks
Trends in Neurosciences|April 5, 2022
Fatty acid balance regulates α-synuclein pathologyStav Cohen-Adiv, Avraham Ashkenazi
Trends in Molecular Medicine|June 4, 2026
Deubiquitinases at organelle quality control bottlenecks in neurodegenerationLisa M Ellerby, Avraham Ashkenazi
Biochemistry|August 17, 2012
Intramolecular interactions within the human immunodeficiency virus-1 gp41 loop region and their involvement in lipid mergingAvraham Ashkenazi, Elisa Merklinger, Yechiel Shai
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Molecular Therapy. Nucleic Acids|November 18, 2024
A drug candidate for a rare polyalanine disease targeting the protein quality controlSharon Pochtar, Avraham Ashkenazi
Molecular Cell|January 5, 2019
The Cell-Death-Associated Polymer PAR Feeds Forward α-Synuclein Toxicity in Parkinson's DiseaseMaya Donyo, Avraham Ashkenazi
European Biophysics Journal : EBJ|January 25, 2011
Insights into the mechanism of HIV-1 envelope induced membrane fusion as revealed by its inhibitory peptidesAvraham Ashkenazi, Yechiel Shai
Nature Reviews. Molecular Cell Biology|March 24, 2020
Lipids as the key to understanding α-synuclein behaviour in Parkinson diseaseRoni Stok, Avraham Ashkenazi
Nature Reviews. Molecular Cell Biology|February 20, 2026
The emerging importance of UBA6 in ubiquitylation and proteostasisGali Prag, Avraham Ashkenazi
Trends in Cell Biology|September 2, 2019
The Nucleolus as a Proteostasis RegulatorFatima Amer-Sarsour, Avraham Ashkenazi
Luminescence : the Journal of Biological and Chemical Luminescence|March 18, 2009
Luminol-dependent chemiluminescence of human phagocyte cell lines: comparison between DMSO differentiated PLB 985 and HL 60 cellsAvraham Ashkenazi, Robert S Marks
Trends in Neurosciences|April 5, 2022
Fatty acid balance regulates α-synuclein pathologyStav Cohen-Adiv, Avraham Ashkenazi
Trends in Molecular Medicine|June 4, 2026
Deubiquitinases at organelle quality control bottlenecks in neurodegenerationLisa M Ellerby, Avraham Ashkenazi
Biochemistry|August 17, 2012
Intramolecular interactions within the human immunodeficiency virus-1 gp41 loop region and their involvement in lipid mergingAvraham Ashkenazi, Elisa Merklinger, Yechiel Shai
Pageof 5